BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
371 – 380 of 3081
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Digital twins to personalize medicine
- Contribution to journal › Scientific review
-
Mark
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
- Contribution to journal › Article
-
Mark
Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
- Contribution to journal › Article
-
Mark
Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer
- Contribution to journal › Article
-
Mark
A single exercise session improves side-effects of chemotherapy in women with breast cancer : an observational study
- Contribution to journal › Article
-
Mark
Decellularization and antibody staining of mouse tissues to map native extracellular matrix structures in 3D
- Contribution to journal › Article
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
- Contribution to journal › Article
